StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
TD Cowen on Novo Nordisk (NVO): 'Meet Management Highlights Multiple NearTerm Opportunities'
May 11, 2026 9:15 AM
TD Cowen analyst Michael Nedelcovych reiterated a Hold rating and $42.00 price target on Novo Nordisk (NYSE: NVO).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
